Bio­gen touts new ev­i­dence from the gene ther­a­py com­pa­ny it wa­gered $800M on

A year ago, Bio­gen made a big bet on a small gene ther­a­py com­pa­ny. Now they have new ev­i­dence one of their ther­a­pies could work.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.